☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Develop
I-Mab Entered into a Collaboration with Jumpcan to Develop and Commercialize Eftansomatropin Alfa (TJ101) in Mainland China
November 11, 2021
Selecta Collaborates with Ginkgo to Develop Therapeutic Enzymes for the Treatment of Orphan and Rare Diseases
October 27, 2021
Vertex Collaborates with Mammoth Biosciences to Develop In Vivo Gene-Editing Therapies for Genetic Diseases
October 27, 2021
Janssen Enters into a License and Collaboration Agreement with F-star to Develop and Commercialize Multiple Bispecific Antibody Th...
October 21, 2021
Sumitomo Dainippon Pharma Signs a Definitive Agreement with BehaVR to Develop and Commercialize PDTs and Wellness Product for CNS...
October 21, 2021
Ipsen Signs an Exclusive WW Collaboration with Accent to Develop and Commercialize METTL3 Program
October 18, 2021
GSK Enters into a 5-Year Partnership with Cambridge University to Address Kidney and Respiratory Diseases
October 22, 2024
Avacta Therapeutics Collaborates with Tempus AI to Commence AI-Driven Drug Development in Oncology
October 22, 2024
Mastering a Changing Landscape: How to Stay Current with Healthcare Industry Changes
October 18, 2024
CXO Talks: Rashmi Gurnani from AKT Health Analytics in a Riveting Dialogue Exchange with PharmaShots
October 14, 2024
Bayer Collaborates with MOMA Therapeutics for the Development of a Small Molecule Oncology Program
October 9, 2024
Advancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots
September 30, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.